Adnan Khattak
Newcastle Rd, H91 YR71
Gaillimh, C, Ireland
Gaillimh, C, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 01, 2026
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 06, 2026
The Application of AI in Cancer MDT and its Legal Implication.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: March 31, 2026
Artificial Intelligence-Assisted Risk Stratification in Stage II Colorectal Cancer: Multi-Institutional Validation of Semantically Enhanced Deep Learning.
Journal: Gastroenterology
Published: February 14, 2026
Real-world characteristics and outcomes of patients with BRAFV600E-mutant metastatic colorectal cancer in Australia: the COALA project.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Lipid Nanoparticle-Encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ plus Durvalumab Induces an Immunostimulatory Effect within the Tumor Microenvironment in Patients with Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 04, 2025
Metastatic Colorectal Cancer Diagnosed Before Age 35: A Distinct Subset of Early-Onset Disease?
Journal: International journal of cancer
Published: July 08, 2025
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer.
Journal: Clinical colorectal cancer
Published: February 25, 2025
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 10, 2024
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial.
Journal: Nature medicine
Published: July 27, 2024
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: April 03, 2024
Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 25, 2024
Last Updated: 09/26/2026